Lv4
668 积分 2022-04-20 加入
Exploring the landscape of targetable alterations in patients with glioblastoma
1个月前
已完结
Annexin A2 associated with bevacizumab resistance and infiltrative escape in glioblastoma
1个月前
已关闭
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
4个月前
已完结
An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma
4个月前
已完结
Epigenetic evolution of isocitrate dehydrogenase-wildtype glioblastomas
4个月前
已完结
Low-grade IDH -mutant gliomas: from standard post-surgical treatments to novel IDH inhibitors
4个月前
已完结
Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors
4个月前
已完结
The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase–Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3
5个月前
已完结
Masters athletes with abnormal cardiovascular findings: a clinical consensus statement of the European Association of Preventive Cardiology of the ESC and the American College of Cardiology
5个月前
已关闭
Multiplicity Control in Clinical Trials
5个月前
已完结
皖公网安备34019202002308
